-
Hind.Aeronautics
4,294.00 5,675.00(%) -
Zomato Ltd
200.50 146.85(%) -
Aster DM Health.
504.00 558.30(%) -
Reliance Industr
1,269.05 1,156.00(%) -
Tata Motors
684.90 1,179.05(%) -
Jio Financial
232.25 394.70(%) -
Mazagon Dock
2,635.55 920.48(%) -
Vodafone Idea
6.77 6.60(%) -
HDFC Bank
1,836.40 1,880.00(%) -
Suzlon Energy
56.40 37.95(%) -
M & M
2,635.10 1,872.45(%) -
IDFC First Bank
54.63 52.60(%) -
Dixon Technolog.
13,019.00 7,100.05(%) -
I R F C
123.65 108.05(%) -
Bharat Electron
306.50 340.35(%) -
Adani Energy Sol
863.60 588.25(%) -
Asian Paints
2,322.35 2,125.00(%) -
Reliance Power
44.75 54.25(%) -
Hindustan Copper
218.75 195.35(%) -
IndusInd Bank
643.70 605.40(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Dr Reddys Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
- Dr. Reddy's
- BSE Code : 815.0
- ISIN : INE089A01031
-
Today’s Low
1,140.75 -
Today’s High
1,159.25

-
Open
1,159.25 -
Perv Close
1,162.20 -
52W Low
1,092.45 -
52W High
1,421.49
Key Indicators
-
P/E(TTM)
18.42
-
Mar.Cap (₹Cr.)
95,478.38
-
Div & Yield %
0.70
-
Book Value(₹)
322.46
-
Debt-Equity Ratio
-1.55
-
AGM Date
28-Mar-2025
-
EPS
62.12
-
P/E Ratio
18.42
Financials Ratios
-
Debt-Equity Ratio
0.06
-
Mar.Cap (₹Cr.)
95,478.38
-
RONW (%)
21.64
-
ROCE (%)
26.59
Score Board
-
Equity (₹ in Cr.)
83.45
-
BV (₹)
322.50
-
Sales( ₹ in Cr.)
19,483.80
-
NP (in Cr.)
4,284.19
-
NP Var(%)
63.0
-
Div%
800.0
-
CPS (₹)
63.00
-
EPS (₹)
51.30
-
Traded Value (₹ in Lakhs)
95,465.87
-
52 Week High
1,421.49
-
52 Week Low
1,092.45
-
Price BSE
1144.0
-
Price NSE
1,144.00
-
Market Capital( in Cr.)
95,465.87
-
P/C Ratio
18.10
-
P/E Ratio
22.30
-
Price Vs.BV
51.30
-
24-Mar-2025( 01:48)
Corporate News - Dr Re... - <P>Dr. Reddy's Laboratories In...
-
22-Mar-2025( 11:01)
Corporate News - Dr Re... - Dr Reddys Laboratories will ho...
-
13-Mar-2025( 06:46)
Corporate News - Dr. R... - <P>Dr. Reddy's Laboratories&nb...
-
06-Mar-2025( 07:16)
Corporate News - Dr Re... - Dr Reddys Laboratories has all...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|---|
Sales Turnover | 19,483.80 | 16,962.50 | 14,405.20 | 13,349.10 | 11,850.40 | 10,625.50 |
Excise Duty | 19,325.30 | 16,338.00 | 13,921.20 | 13,236.40 | 11,023.10 | 10,502.30 |
Net Sales | 19,483.80 | 16,962.50 | 14,405.20 | 13,349.10 | 11,850.40 | 10,625.50 |
Other Income | 862.30 | 591.30 | 482.00 | 801.10 | 743.20 | 238.40 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Income | 20,346.10 | 17,553.80 | 14,887.20 | 14,150.20 | 12,593.60 | 10,863.90 |
EXPENDITURE : | ||||||
Raw Materials | 19,325.30 | 16,338.00 | 13,921.20 | 13,236.40 | 11,023.10 | 10,502.30 |
Power & Fuel Cost | 19,325.30 | 16,338.00 | 13,921.20 | 13,236.40 | 11,023.10 | 10,502.30 |
Employee Cost | 3,085.70 | 2,832.60 | 2,434.60 | 2,270.10 | 2,030.20 | 1,931.90 |
Other Manufacturing Expenses | 357.40 | 406.10 | 292.00 | 300.00 | 245.10 | 269.80 |
Selling & Administrative Expenses | 3,064.60 | 2,782.80 | 2,672.90 | 2,274.90 | 2,026.80 | 2,001.20 |
Miscellaneous Expenses | 357.40 | 406.10 | 292.00 | 300.00 | 245.10 | 269.80 |
Less : Pre-operative Expenses Capitalised : | ||||||
Total Expenditure | 14,554.80 | 13,687.80 | 12,663.40 | 11,094.00 | 9,817.80 | 9,163.20 |
Operating Profit | 2,010.40 | 1,656.00 | 1,365.70 | 1,244.30 | 1,104.90 | 1,085.10 |
Interest | 21.80 | 16.90 | 38.00 | 46.70 | 47.80 | 56.80 |
Gross Profit | 5,791.30 | 3,866.00 | 2,223.80 | 3,056.20 | 2,775.80 | 1,700.70 |
Depreciation | 975.60 | 923.20 | 814.30 | 835.00 | 789.20 | 780.60 |
Profit Before Tax | 5,791.30 | 3,866.00 | 2,223.80 | 3,056.20 | 2,775.80 | 1,700.70 |
Tax | 1,361.80 | 864.10 | 392.60 | 540.10 | 483.90 | 281.80 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 87.50 | 389.10 | 208.00 | 329.70 | -645.80 | 141.60 |
Reported Net Profit | 4,342.00 | 2,612.80 | 1,623.20 | 2,186.40 | 2,937.70 | 1,277.30 |
Extraordinary Items | 5,791.30 | 3,866.00 | 2,223.80 | 3,056.20 | 2,775.80 | 1,700.70 |
Adjusted Net Profit | 4,342.00 | 2,612.80 | 1,623.20 | 2,186.40 | 2,937.70 | 1,277.30 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Statutory Appropriations | 667.30 | 666.11 | 499.28 | 415.75 | 415.43 | 332.13 |
P & L Balance carried down | 4,342.00 | 2,612.80 | 1,623.20 | 2,186.40 | 2,937.70 | 1,277.30 |
Dividend | - | - | - | - | - | - |
Preference Dividend | - | - | - | - | - | - |
Equity Dividend (%) | 800.00 | 800.00 | 600.00 | 500.00 | 500.00 | 400.00 |
Dividend Per Share(Rs) | 40.00 | 40.00 | 30.00 | 25.00 | 25.00 | 20.00 |
Earnings Per Share-Unit Curr | 260.95 | 157.37 | 97.85 | 131.84 | 177.23 | 76.98 |
Book Value | 667.30 | 666.11 | 499.28 | 415.75 | 415.43 | 332.13 |
Book Value(Adj)-Unit Curr | 667.30 | 666.11 | 499.28 | 415.75 | 415.43 | 332.13 |